USA - NASDAQ:NAYA - US44984F4019 - Common Stock
The current stock price of NAYA is 2.2 USD. In the past month the price decreased by -7.56%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.42 | 220.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.47 | 195.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.27 | 149.82B | ||
| SYK | STRYKER CORP | 29.71 | 145.96B | ||
| MDT | MEDTRONIC PLC | 16.94 | 120.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.02 | 53.26B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.61 | 44.68B | ||
| RMD | RESMED INC | 27.17 | 37.87B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 35.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.26 | 27.76B | ||
| DXCM | DEXCOM INC | 41.37 | 27.58B |
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
NAYA BIOSCIENCES INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 25
Phone: 19788789505
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
The current stock price of NAYA is 2.2 USD. The price increased by 8.37% in the last trading session.
NAYA does not pay a dividend.
NAYA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
NAYA BIOSCIENCES INC (NAYA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.96).
NAYA BIOSCIENCES INC (NAYA) has a market capitalization of 1.47M USD. This makes NAYA a Nano Cap stock.
ChartMill assigns a fundamental rating of 1 / 10 to NAYA. NAYA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NAYA reported a non-GAAP Earnings per Share(EPS) of -2.96. The EPS increased by 76.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.87% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed NAYA and the average price target is 6.12 USD. This implies a price increase of 178.18% is expected in the next year compared to the current price of 2.2.
For the next year, analysts expect an EPS growth of -3770% and a revenue growth 125.23% for NAYA